Physicians’ Opinions Survey on FDA’s Bydureon Approval

2012-03-06
Published : Mar-2012

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Filtration Paper Market 2017-2021

Filtration, a technique used to separate solids from liquids, is the act of pouring a mixture onto a membrane (filter paper) that allows the passage of liquid (the filtrate) and results in the collection of the solid. The analysts forecast the global filtration paper market to grow at a CAGR of 4.16% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global filtration paper market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of filter papers. The market is divided into the following segments based on geography: APAC Europe North America ROW The report, Global Filtration Paper Market 2017-2021, has been prepared based on an in-depth mark......
$3500

Global Healthcare Cloud Computing Market 2017-2021

Cloud computing helps enterprises effectively reduce their capital and operational costs. It is gaining traction in the global healthcare industry as organizations are adopting an information-centric business approach. The demand for on-premises software solutions in the healthcare industry has receded due to the growing adoption of cloud-based solutions. Polycom, a US-based firm that manufactures video conferencing equipment, is offering cloud-based on-demand video conferencing solutions that help reduce on-premises infrastructure costs. Cloud-based telehealth services eliminate the need to install hardware and other infrastructure that is set up in hospitals and telecardiology centers. The analysts forecast global healthcare cloud computing market to grow at a CAGR of 21.24% during th......
$3500

Global Diabetic Therapeutic Market 2017-2021

The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year. The analysts forecast the global diabetic therapeutic market to grow at a CAGR of 7.55% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global diabetic therapeutic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded drugs, generics, and biosimilars used for the treatment of diabetes.......
$3500

Global Coagulation Testing Market 2017-2021

Coagulation testing helps measure the ability of blood to form a clot. Clotting occurs when blood converts from liquid to gel form. Coagulation tests are performed to analyze clotting disorders, such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving the quality of life of patients. The analysts forecast the global coagulation testing market to grow at a CAGR of 6.43% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global coagulation testing market for 2017-2021. To calculate the market size, the ......
$3500

Global MRSA Testing Market 2017-2021

MRSA has been a major cause of concern due to the long-term use of antibiotics, which is now deemed as unnecessary. The inappropriate use of antibiotics may contribute to the rise in drug-resistant bacteria because they do not destroy the bacteria completely. This has been one of the major factors influencing the use of MRSA testing in the medical industry. With this, there is focus on the development of rapid MRSA testing products with greater sensitivity for detection. The analysts forecast the global MRSA testing market to grow at a CAGR of 11.09% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global MRSA testing market for 2017-2021. To calculate the market size, the report considers the new installat......
$3500

Global Atopic Dermatitis Drugs Market 2017-2021

Atopic dermatitis is a common, chronic, relapsing, inflammatory disease that primarily affects young children. Atopy refers to an inherited tendency to produce IgE antibodies, whereas, dermatitis means inflammation of the skin. Atopic dermatitis is associated with asthma, inhalant allergies (hay fever), and chronic dermatitis. In this condition, the skin becomes extremely itchy and inflamed, which causes redness, cracking, weeping, swelling, vesicle formation, crushing, and scaling. Atopic dermatitis is very common worldwide, and its prevalence rate is increasing. The data estimates suggest that nearly 60% of the patients develop symptoms in the first year of life, and 88%-92% develop symptoms before the age of five. The analysts forecast the global atopic dermatitis drugs market to gro......
$3500

Global Critical Care Therapeutics Market 2017-2021

About Critical Care Therapeutics Critical care or intensive care is the close monitoring and treatment given to individuals with acute, life-threatening illness or injuries such as shock, burns, accidents, complicated surgeries, sepsis, and severe breathing problems. It usually takes place in an ICU or trauma center. Plasma is the fluid portion of the blood, in which all the blood cells are suspended. It makes up about 55% of the total volume of the blood. The other components such as red blood cell (RBC), white blood cell (WBC), and platelets together comprise the remaining 45% of the blood. Plasma is mainly made up of water, which accounts for about 91% of the total volume. The analysts forecast global critical care therapeutics market to grow at a CAGR of 3.62% during the period 201......
$3500

Global Pharmaceutical Excipients Market 2017-2021

About Pharmaceutical Excipients Pharmaceutical excipients are inert substances that are generally used to manufacture different forms of drugs and are present in the finished products. Excipients help in providing long-term stability and make solid formulations bulkier. They also improve the functionality of drugs and make them safer. The analysts forecast global pharmaceutical excipients market to grow at a CAGR of 6.53% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global pharmaceutical excipients market for 2017-2021. To calculate the market size, the report considers the sales of pharmaceutical excipients based on their functionalities, which include binders and fillers, coating agents, disintegrant......
$3500

Global Pharmerging Markets 2017-2021

The immense growth potential in pharmerging market has driven large multinational pharmaceutical companies to focus on these regions by pursuing organic as well as in-organic routes. To make in-roads into the new geography, the large players usually take in-organic route through strategic expansion initiatives such as acquisitions and alliances. For instance, in December 2015, AstraZeneca entered into a deal with WuXi to acquire its biologics manufacturing facilities in China to expand locally. The analysts forecast global pharmerging market to grow at a CAGR of 12.88% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global pharmerging market for 2017-2021. To calculate the market size, the report considers......
$3500

Global Myasthenia Gravis Drugs Market 2017-2021

Currently, the myasthenia gravis drugs market stands at a small size due to limited availability of approved therapies for the complete remission of the disease. However, the anticipated approval of novel drugs such as monoclonal antibodies should help market witness strong growth during the forecast period. For instance, Alexion Pharmaceuticals is currently developing a monoclonal antibody, Soliris, for the treatment of myasthenia gravis. Once launched around end 2017 or beginning of 2018, this drug is expected to be the blockbuster drug for the market. The analysts forecast global myasthenia gravis drugs market to grow at a CAGR of 13.16% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global myasthenia ......
$3500